Résultats carcinologiques après prostatectomie totale pour cancer: Validation française de la classification de D'Amico;Oncologic outcomes after radical prostatectomy: French validation of the D'Amico risk group classification

Progres en Urologie

Volumn 20, Issue 13, 2010, Pages 1206-1212

  Ouzzane, A ^a   Koenig, P ^a   Ballereau, C ^a   Zini, L ^a   Ghoneim, T ^a   Maladry, F ^a   Fantoni, J C ^a   Biserte, J ^a   Leroy, X ^b   Villers, A ^a  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

antigen; Long term; Prostate cancer; Prostate specificue; Prostatectomy; Risk factor

Indexed keywords

AGED; ARTICLE; CLASSIFICATION; HUMAN; LANGUAGE; MALE; METHODOLOGY; MIDDLE AGED; PROSTATE TUMOR; PROSTATECTOMY; RETROSPECTIVE STUDY; RISK ASSESSMENT; TUMOR RECURRENCE; VALIDATION STUDY;

AGED; HUMANS; LANGUAGE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 78649862391     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2010.05.015     Document Type: Article

References (18)

1. Shariat S.F., Karakiewicz P.I., Roehrborn C.G., Kattan M.W. An updated catalog of prostate cancer predictive tools. Cancer 2008, 113:3075-3099.
2. Kattan M.W., Wheeler T.M., Scardino P.T. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999, 17:1499-1507.
3. Eggener S.E., Vickers A.J., Serio A.M., Donovan M.J., Khan F.M., Bayer-Zubek V., et al. Comparison of models to predict clinical failure after radical prostatectomy. Cancer 2009, 115:303-310.
4. D'Amico A.V., Whittington R., Malkowicz S.B., Schultz D., Blank K., Broderick G.A., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998, 280:969-974.
5. Soulie M., Beuzeboc P., Cornud F., Eschwege P., Gaschignard N., Grosclaude P., et al. Cancer de la prostate. Prog Urol 2007, 17:1159-1230.
6. McNeal J.E., Redwine E.A., Freiha F.S., Stamey T.A. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988, 12:897-906.
7. Jegu J, Tretarre B, Velten M, Guizard AV, Danzon A, Buemi A, et al. Le cancer de la prostate en France en 2001: état des pratiques et facteurs associés à la réalisation d'une prostatectomie totale. Prog Urol 2010;20:56-64.
8. Boorjian S.A., Karnes R.J., Rangel L.J., Bergstralh E.J., Blute M.L. Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy. J Urol 2008, 179:1354-1360. [discussion, 1360-1].
9. Kattan M.W., Eastham J.A., Stapleton A.M., Wheeler T.M., Scardino P.T. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998, 90:766-771.
10. Touijer K., Secin F.P., Cronin A.M., Katz D., Bianco F., Vora K., et al. Oncologic outcome after laparoscopic radical prostatectomy: 10 years of experience. Eur Urol 2009, 55:1014-1019.
11. Cronin AM, Godoy G, Vickers AJ. Definition of biochemical recurrence after radical prostatectomy does not substantially impact prognostic factor estimates. J Urol 2010;183:984-9.
12. Ploussard G., Salomon L., Allory Y., Terry S., Vordos D., Hoznek A., et al. Pathological findings and prostate-specific antigen outcomes after laparoscopic radical prostatectomy for high-risk prostate cancer. BJU Int 2009, 106(1):86-90.
13. Han M., Partin A.W., Pound C.R., Epstein J.I., Walsh P.C. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001, 28:555-565.
14. Eastham J.A., Kattan M.W., Riedel E., Begg C.B., Wheeler T.M., Gerigk C., et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 2003, 170:2292-2295.
15. Kordan Y, Salem S, Chang SS, Clark PE, Cookson MS, Davis R, et al. Impact of positive apical surgical margins on likelihood of biochemical recurrence after radical prostatectomy. J Urol 2009;182:2695-701.
16. Alkhateeb S, Alibhai S, Fleshner N, Finelli A, Jewett M, Zlotta A, et al. Impact of positive surgical margins after radical prostatectomy differs by disease risk group. J Urol 2010;183:145-50.
17. Pontvert D., Gaboriaud G., Flam T., Jourdan-Da Silva N., Thiounn N., Mammar H., et al. Radiothérapie conformationnelle à 76 Gy des cancers localisés de la prostate. Modalités thérapeutiques et résultats préliminaires. Cancer Radiother 2008, 12:78-87.
18. Cosset J.M., Flam T., Thiounn N., Gomme S., Rosenwald J.C., Asselain B., et al. Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital group on 809 patients. Int J Radiat Oncol Biol Phys 2008, 71:1042-1048.